z-logo
open-access-imgOpen Access
Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report
Author(s) -
Carmen Bobeică,
Laura Rebegea,
Gabriel Murariu,
Michaela Dobre,
Aurel Nechita,
Alin Laurenţiu Tatu,
Eleiculeț,
Lucreția Anghel,
Silvia Fotea,
Mihaela Crăescu
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10937
Subject(s) - medicine , lung cancer , pembrolizumab , oncology , adverse effect , cancer , adenocarcinoma , epidermal growth factor receptor , treatment of lung cancer , radiation therapy , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom